Search Results

Rasagiline best for early Parkinson's disease

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 3-3(1)

Publisher: Adis International

Escitalopram/rasagiline interaction: First report of an interaction, leading to confusion and hallucinations in an elderly patient: case report

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 17-18(2)

Publisher: Adis International

Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation

Authors: Haycox, Alan; Armand, Christophe; Murteira, Susana; Cochran, John; François, Clément

Source: Drugs & Aging, Volume 26, Number 9, 1 September 2009 , pp. 791-801(11)

Publisher: Adis International

Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease

Authors: Naoi, Makoto; Maruyama, Wakako

Source: Expert Review of Neurotherapeutics, Volume 9, Number 8, August 2009 , pp. 1233-1250(18)

Publisher: Expert Reviews

Levodopa/carbidopa/rasagiline: Malignant melanoma (first report with rasagiline) in an elderly patient: case report

Source: Reactions, Volume 1, Number 1261, 2009-07-18 , pp. 19-19(1)

Publisher: Adis International

Economically, initiating treatment for Parkinson's disease with rasagiline dominates initiating treatment with ropinirole

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 581, 2009-06-27 , pp. 8-8(1)

Publisher: Adis International

In a recent report, Decision Resources suggests that second-line patient share of monoamine oxidase B (MAO B) inhibitors has increased

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 574, 2009-03-21 , pp. 7-7(1)

Publisher: Adis International

The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy

Authors: Elmer, Lawrence W; Bertoni, John M

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 16, November 2008 , pp. 2759-2772(14)

Publisher: Informa Healthcare

Rasagiline reaps rewards in Parkinson's disease

Source: Inpharma, Volume 1, Number 1653, 2008-08-30 , pp. 14-14(1)

Publisher: Adis International

Levodopa/carbidopa/entacapone/rasagiline: Serotonin syndrome (first report with rasagiline and entacapone) in an elderly patient: case report

Source: Reactions, Volume 1, Number 1213, 2008-08-02 , pp. 23-23(1)

Publisher: Adis International

Impact of Newer Pharmacological Treatments on Quality of Life in Patients with Parkinson's Disease

Authors: Gallagher, David A.; Schrag, Anette

Source: CNS Drugs, Volume 22, Number 7, 2008 , pp. 563-586(24)

Publisher: Adis International

ADAGIO results music to the ears of Parkinson's patients

Source: Inpharma, Volume 1, Number 1643, 2008-06-21 , pp. 17-17(1)

Publisher: Adis International

Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration

Authors: Zhu, Wen; Xie, Wenjie; Pan, Tianhong; Jankovic, Joseph; Li, Jun; Youdim, Moussa B. H.; Le, Weidong

Source: Journal of Neurochemistry, Volume 105, Number 5, June 2008 , pp. 1970-1978(9)

Publisher: Blackwell Publishing

Levodopa/pramipexole/rasagiline: Tics in a patient with Parkinson's disease: case report

Source: Reactions, Volume 1, Number 1198, 2008-04-19 , pp. 30-30(1)

Publisher: Adis International

Progress in neuroprotection in Parkinson's disease

Author: Schapira, A. H. V.

Source: European Journal of Neurology, Volume 15, Supplement 1, April 2008 , pp. 5-13(9)

Publisher: Blackwell Publishing

Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 1, January 2008 , pp. 17-21(5)

Publisher: Adis International

Spotlight on Rasagiline in Parkinson's Disease

Authors: Oldfield, Vicki; Keating, Gillian M.; Perry, Caroline M.

Source: CNS Drugs, Volume 22, Number 1, 2008 , pp. 83-86(4)

Publisher: Adis International

Outcomes associated with pharmacologic treatments in Parkinson's disease: a review of recent literature

Authors: Iaconi, Ala I; Zimmerman, Marliese A; Kulkarni, Amit S; Balkrishnan, Rajesh

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 2, February 2008 , pp. 163-174(12)

Publisher: Informa Healthcare

Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil

Authors: WEINREB, ORLY; AMIT, TAMAR; BAR-AM, ORIT; YOUDIM, MOUSSA B.H.

Source: Annals of the New York Academy of Sciences, Volume 1122, Number 1, December 2007 , pp. 155-168(14)

Publisher: Blackwell Publishing

Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro

Authors: Bar-Am, Orit; Amit, Tamar; Youdim, Moussa B. H.

Source: Journal of Neurochemistry, Volume 103, Number 2, October 2007 , pp. 500-508(9)

Publisher: Blackwell Publishing